Healthcare provider profile · identity verified

Rene Rodriguez, ARNP

Family Practice · MIAMI, FL · NPI 1033710777

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Vitamin D2	Ergocalciferol (Vitamin D2)	1360	244
Atorvastatin Calcium	Atorvastatin Calcium	922	194
Rosuvastatin Calcium	Rosuvastatin Calcium	720	143
Gabapentin	Gabapentin	656	128
Metformin Hcl	Metformin Hcl	620	122
Levothyroxine Sodium	Levothyroxine Sodium	557	96
Omeprazole	Omeprazole	468	94
Losartan Potassium	Losartan Potassium	466	86
Amlodipine Besylate	Amlodipine Besylate	460	78
Folic Acid	Folic Acid	441	88
Tamsulosin Hcl	Tamsulosin Hcl	422	73
Lisinopril	Lisinopril	417	74
Pantoprazole Sodium	Pantoprazole Sodium	350	78
Sildenafil Citrate	Sildenafil Citrate	350	69
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	349	58
Montelukast Sodium	Montelukast Sodium	293	64
Hydrochlorothiazide	Hydrochlorothiazide	287	59
Clopidogrel	Clopidogrel Bisulfate	283	46
Metoprolol Tartrate	Metoprolol Tartrate	263	40
Metoprolol Succinate	Metoprolol Succinate	236	41
Famotidine	Famotidine	224	42
Glipizide	Glipizide	212	44
Ibuprofen	Ibuprofen	206	93
Glipizide Er	Glipizide	161	38
Furosemide	Furosemide	158	34
Albuterol Sulfate Hfa	Albuterol Sulfate	155	44
Pioglitazone Hcl	Pioglitazone Hcl	150	25
Alendronate Sodium	Alendronate Sodium	136	36
Alcohol Prep Pads	Alcohol Antiseptic Pads	130	45
Benzonatate	Benzonatate	114	82
Tadalafil	Tadalafil	95	31
Carvedilol	Carvedilol	92	20
Simvastatin	Simvastatin	92	25
Methocarbamol	Methocarbamol	86	46
Meclizine Hcl	Meclizine Hcl	85	35
Finasteride	Finasteride	81	15
Atenolol	Atenolol	79	12
Fenofibrate	Fenofibrate Nanocrystallized	79	21
Azithromycin	Azithromycin	78	64
Pentoxifylline	Pentoxifylline	75	16
Oxybutynin Chloride Er	Oxybutynin Chloride	69	suppressed
Diclofenac Sodium	Diclofenac Sodium	68	32
Enalapril Maleate	Enalapril Maleate	67	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	66	34
Nifedipine Er	Nifedipine	64	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	12
Isosorbide Dinitrate	Isosorbide Dinitrate	61	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	55	suppressed
Fenofibrate	Fenofibrate	50	13
Glimepiride	Glimepiride	46	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	46	suppressed
Fluticasone Propionate	Fluticasone Propionate	44	16
Spironolactone	Spironolactone	43	suppressed
Hydralazine Hcl	Hydralazine Hcl	40	11
Allopurinol	Allopurinol	39	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Donepezil Hcl	Donepezil Hcl	36	14
Lactulose	Lactulose	36	16
Metformin Hcl Er	Metformin Hcl	36	suppressed
Entresto	Sacubitril/Valsartan	35	suppressed
Eliquis	Apixaban	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	25
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Memantine Hcl	Memantine Hcl	32	13
Latanoprost	Latanoprost	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Ammonium Lactate	Ammonium Lactate	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Prednisone	Prednisone	27	20
Triamcinolone Acetonide	Triamcinolone Acetonide	26	18
Quetiapine Fumarate	Quetiapine Fumarate	25	15
Dutasteride	Dutasteride	23	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Timolol Maleate	Timolol Maleate	22	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Ciclopirox	Ciclopirox Olamine	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Nifedipine	Nifedipine	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Diclofenac Potassium	Diclofenac Potassium	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	11
Repaglinide	Repaglinide	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Amoxicillin	Amoxicillin	13	12
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Propafenone Hcl	Propafenone Hcl	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Edarbyclor	Azilsartan Med/Chlorthalidone	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Combigan	Brimonidine Tartrate/Timolol	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error